Join
Live feed
·
NEWSReleasevia Quantisnow
Finch Therapeutics Group Inc. logo

Finch Therapeutics Has Been Granted European Patent Number EP3664823 Titled "Composition For Use In Preventing Or Treating An Enterococcal Blood Stream Infection".

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FNCH (Finch Therapeutics Group Inc.) and more on Quantisnow.